PowerShell cross-platform limitations break Windows-only cmdlets, .NET dependencies, and Windows Forms GUIs on Linux. Dual booting and WinBoat enable Windows PowerShell compatibility but introduce ...
This Azure DevOps extension allows you to upload build artifacts to Buildstash. Buildstash is a platform for software teams to manage all their past builds, organize, share with team members, and ...
The Cleveland Guardians continue to demonstrate a keen eye for international pitching talent with the addition of 22-year-old Ettore Giulianelli from Rimini, Italy. The right-handed pitcher joins the ...
Editor's take: Microsoft is doubling down on its plan to turn Windows 11 into an "agentic AI" platform, and in the process seems determined to strip away the last bits of user agency left in the OS.
As part of the December 2025 Patch Tuesday Update for Windows 11 version 23H2, 24H2, and 25H2, Microsoft made some changes to PowerShell 5.1. So, if you came across a new security warning in Windows ...
Azure DevOps Server is now generally available, marking its transition to a production-ready on-premises offering for teams that need to self-host their DevOps platform. The GA release packages ...
Major U.S. airlines have prepared contingency plans – some involving extra fuel stops – during the Thanksgiving holiday travel week, after a pipeline leak disrupted jet fuel deliveries to ...
The Nationals protected a trio of prospects from the 2025 Rule 5 Draft on Tuesday. Washington selected the contracts of left-hander Jake Bennett (No. 10 prospect, per MLB Pipeline), outfielder ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Abstract: PowerShell is a widely utilized tool by both system administrators and attackers for performing complex management tasks and launching attacks. The detection of malicious scripts poses a ...
Novartis (NVS) has announced that it will acquire Tourmaline Bio, Inc. (TRML), a New York-based, publicly traded clinical-stage biopharmaceutical company, for $1.4 billion. The acquisition will add ...